Clinical Trials Office
Clinical Trials Office
批准号:
7714242
负责人:
HOWARD S HOCHSTER
金额:
$10.28万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-18 至 2013-02-28
关键词:
AppointmentBudgetsCancer CenterClinicalClinical InvestigatorClinical ResearchClinical TrialsClosureConduct Clinical TrialsCritiquesDataData AnalysesData CollectionDevelopmentDiscipline of NursingEnsureEnvironmentFunding AgencyGoalsGrowthGuidelinesInstitutesInstitutionMalignant NeoplasmsMedicalMedical centerMeta-AnalysisModelingNumbersOutcomeProceduresProcessProtocols documentationQuality ControlReportingResearchResearch Ethics CommitteesResearch PersonnelResourcesServicesStandards of Weights and MeasuresTherapy Clinical TrialsTimeTranslatinganticancer researchconceptdata managementimprovedinterdisciplinary collaborationmedical schoolsnovelprogramsprotocol developmentquality assuranceresponsesuccess
中文摘要
临床试验办公室(CTO)为癌症提供行政、研究和教育服务
进行临床试验的研究机构研究人员和研究人员。它作为主要的协调中心
癌症相关临床试验从概念开发、提交到结束,包括方案
制定、监管和合规指南、行政申报、数据收集和数据
管理,数据分析和质量控制功能,并作为其他管理界面
纽约大学医学中心的临床研究组织。该资源的目标是:
通过为临床试验的开发、提交和实施提供框架,促进临床试验
审判
加强和促进临床癌症研究数据的收集和报告。
为CTO员工和临床研究者提供教育计划。
促进跨学科合作,并为将研究成果转化为临床竞技场提供场所
针对先前的批评、内部审计和外部顾问的审查,
自上次审查以来,CTO内部发生了变化。这些变化包括任命
新的医疗和行政主任,新的标准操作程序,以及数据重组
管理这些改进产生了一个更好地满足调查人员需求的CTO
在纽约大学医学院的临床研究环境中表现得更有效。目前
CTO监督49名研究人员,管理158个开放协议。首席技术官继续扩大,
完善其功能,作为临床研究企业的中央协调中心,
纽约大学CI。
英文摘要
The Clinical Trials Office (CTO) provides administrative, research and educational services to the Cancer
Institute investigators and research staff conducting clinical trials. It serves as the main coordinating center
for cancer-related clinical trials from concept development and submission to closure including protocol
development, regulatory and compliance guidance, administrative submissions, data collection and data
management, data analysis, and quality control functions, and serves as the administrative interface to other
clinical research organizations at the NYU Medical Center. The goals of this resource are to:
Facilitate clinical trials by providing a framework for development, submission, and conduct of dinical
trials.
Enhance and facilitate data collection and reporting of clinical cancer research data.
Provide educational programs for the CTO staff and clinical investigators.
Promote interdisciplinary collaboration and a venue for translating research findings to the clinical arena
In response to the previous critique, internal audits, and the review of external consultants, significant
changes have occurred within the CTO since the last review. These changes include the appointment of
new medical and administrative directors, new standard operating procedures, and restructuring of data
management. These improvements have produced a CTO that better meets the needs of investigators
performs more effectively within the NYU School of Medicine clinical research environment. Currently, the
CTO supervises 49 research staff and manages 158 open protocols. The CTO continues to expand and
improve its function to serve as the central coordinating center for the clinical research enterprise at the
NYUCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN
-
批准号:8839216
-
项目类别:
-
资助金额:$55.15万
-
财政年份:2014
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CLINICAL TRIAL: CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLOR
-
批准号:7718426
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CLINICAL TRIAL: ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCE
-
批准号:7718420
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7605733
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7605716
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG N0147: OXAL PLUS 5-FU/CF W/WO CETUXIMAB IN STAGE III COLON CANCERECOG N0
-
批准号:7605775
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7378324
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7378319
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLORECTAL CANCER
-
批准号:7378335
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7378298
-
项目类别:
-
资助金额:$2.95万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:6988335
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
THE FARNESYL TRANSFERASE INHIBITOR R115777 IN COMBINATION WITH TOPOTECAN
-
批准号:7207064
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7207168
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7409167
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
N9831: DOXORUBICIN/CYCLOPHOSPHAMIDE/TAXOL +OR -TRASTUZUMAB FOR BREAST CANCER
-
批准号:7207067
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7089043
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7207141
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7207173
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7226213
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG E3201: PHASE III STUDY IN PATIENTS WITH STAGE II OR III RECTAL CANCER
-
批准号:7207162
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
海外基金